The meditation app developer has quadrupled its valuation to $1bn in just eight months, in an $88m series B round featuring CAA.

The data centre and cloud security software provider, which is backed by Telstra and Citi, has increased its funding to $127m altogether.

Nan Fung Life Sciences and Novo have taken part in a series B round for Stanford's immuno-oncology drug developer Bolt Biotherapeutics.

Nan Fung Life Sciences and Novo have taken part in the immuno-oncology drug developer's series B round, which was led by Pivotal BioVenture Partners.

The BBVA and USAA-backed digital wealth manager has now raised about $265m altogether, after scoring $50m in a series F round led by IGM Financial.

Hiscox has led CoverHound's series D round, which also attracted Chubb, Aflac and MS&AD, bringing the insurance comparison platform’s overall funding to more than $112m.

Pharmaceutical company Sosei has launched new companies using technology from its 2015 acquisition of Heptares, both of which have received funding from Medicxi.

Better Mortgage boosted its overall funding to about $115m, closing a series C round in which American Express Ventures came onboard as an investor.

Simon Ventures-backed subscription commerce platform FabFitFun has added $80m in series A capital to its coffers nine years after it launched as a lifestyle newsletter.

The General Electric-backed oilfield services marketplace operator has reportedly increased its valuation to $300m following a round led by Founders Fund.